ARCHIVES

Special Report: KRAS Finding Changes Oncology Practice But Poses Profound Regulatory Dilemma

This article is from The Cancer Letter archive.

Vol. 35 No. 04 | January 30, 2009

Download PDF Visit The Full Archive

Related Articles

Drug Approved in Europe For Pediatric Cancer Patients

April 24, 2009

Concepts Approved for Primary Care, Worker Health, Black Interventions

May 17, 1985

Iniparib Doesn’t Meet Survival, PFS Endpoints In Phase III Trial in Triple-Negative Breast Cancer

February 25, 2011

WHI Investigators Reiterate: Breast Cancer, CHD Risks Too Great For Routine HT Use

November 2, 2002

FDA approves Irinotecan, Days After ODAC Meeting

June 21, 1996

GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer.

November 2, 2007